Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome.
De Matteis S, Del Coco L, De Castro F, Giudetti AM, Casadei B, Iannotta F, De Felice F, Tomassini E, Vaglio F, Naddeo M, Salamon I, Storci G, Laprovitera N, Messelodi D, Bertuccio SN, Tassoni M, Sinigaglia B, Barbato F, Ursi M, Campanini E, Maffini E, Roberto M, Pellegrini C, Dan E, Pirazzini C, Garagnani P, Ferracin M, Zinzani PL, Fanizzi FP, Bonafè M, Bonifazi F.
De Matteis S, et al. Among authors: del coco l.
Haematologica. 2025 Jul 1;110(7):1545-1554. doi: 10.3324/haematol.2024.285154. Epub 2024 Dec 19.
Haematologica. 2025.
PMID: 39704157
Free PMC article.